Circulating Cell-Free DNA An Up-Coming Molecular Marker in Exercise Physiology

被引:162
|
作者
Breitbach, Sarah [1 ]
Tug, Suzan [1 ]
Simon, Perikles [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Sports Med, Fac Social Sci Media & Sport, D-55128 Mainz, Germany
关键词
FREE PLASMA DNA; RESISTANCE EXERCISE; HUMAN-LEUKOCYTES; SKELETAL-MUSCLE; FETAL DNA; LYMPHOCYTE APOPTOSIS; BIOCHEMICAL MARKERS; ECCENTRIC EXERCISE; STRENUOUS EXERCISE; XANTHINE-OXIDASE;
D O I
10.2165/11631380-000000000-00000
中图分类号
G8 [体育];
学科分类号
04 ; 0403 ;
摘要
The phenomenon of circulating cell-free DNA (cfDNA) concentrations is of importance for many biomedical disciplines including the field of exercise physiology. Increases of cfDNA due to exercise are described to be a potential hallmark for the overtraining syndrome and might be related to, or trigger adaptations of, immune function induced by strenuous exercise. At the same time, exercise provides a practicable model for studying the phenomenon of cfDNA that is described to be of pathophysiological relevance for different topics in clinical medicine like autoimmune diseases and cancer. In this review, we are summarizing the current knowledge of exercise-based acute and chronic alterations in cfDNA levels and their physiological significance. The effects of acute exercise on cfDNA concentrations have been investigated in resistance exercises and in continuous, stepwise and interval endurance exercises of different durations. cfDNA concentrations peaked immediately after acute exercise and showed a rapid return to baseline levels. Typical markers of skeletal muscle damage (creatine kinase, uric acid, C-reactive protein) show delayed kinetics compared with the cfDNA peak response. Exercise parameters such as intensity, duration or average energy expenditure do not explain the extent of increasing cfDNA concentrations after strenuous exercise. This could be due to complex processes inside the human organism during and after physical activity. Therefore, we hypothesize composite effects of different physiological stress parameters that come along with exercise to be responsible for increasing cfDNA concentrations. We suggest that due to acute stress, cfDNA levels increase rapidly by a spontaneous active or passive release mechanism that is not yet known. As a result of the rapid and parallel increase of cfDNA and lactate in an incremental treadmill test leading to exhaustion within 15-20 minutes, it is unlikely that cfDNA is released into the plasma by typical necrosis or apoptosis of cells in acute exercise settings. Recently, rapid DNA release mechanisms of activated immune-competent cells like NETosis (pathogen-induced cell death including the release of neutrophil extracellular traps [NETs]) have been discovered. cfDNA accumulations might comprise a similar kind of cell death including trap formation or an active release of cfDNA. Just like chronic diseases, chronic high-intensity resistance training protocols induced persistent increases of cfDNA levels. Chronic, strenuous exercise protocols, either long-duration endurance exercise or regular high-intensity workouts, induce chronic inflammation that might lead to a slow, constant release of DNA. This could be due to mechanisms of cell death like apoptosis or necrosis. Yet, it has neither been implicated nor proven sufficiently whether cfDNA can serve as a marker for overtraining. The relevance of cfDNA with regard to overtraining status, performance level, and the degree of physical exhaustion still remains unclear. Longitudinal studies are required that take into account standardized and controlled exercise, serial blood sampling, and large and homogeneous cohorts of different athletic achievement. Furthermore, it is important to establish standardized laboratory procedures for the measurement of genomic cfDNA concentrations by quantitative real-time polymerase chain reaction (PCR). We introduce a new hypothesis based on acute exercise and chronic exposure to stress, and rapid active and passive chronic release of cfDNA fragments into the circulation.
引用
收藏
页码:565 / 586
页数:22
相关论文
共 50 条
  • [1] Circulating Cell-Free DNAAn Up-Coming Molecular Marker in Exercise Physiology
    Sarah Breitbach
    Suzan Tug
    Perikles Simon
    [J]. Sports Medicine, 2012, 42 : 565 - 586
  • [2] Circulating, cell-free DNA as a marker for exercise load in intermittent sports
    Haller, Nils
    Helmig, Susanne
    Taenny, Pascal
    Petry, Julian
    Schmidt, Sebastian
    Simon, Perikles
    [J]. PLOS ONE, 2018, 13 (01):
  • [3] Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
    Yu, Ming
    Zhu, Yu
    Teng, Lichen
    Cui, Jialin
    Su, Yajuan
    [J]. JOURNAL OF ONCOLOGY, 2021, 2021
  • [4] Circulating cell-free DNA as a potential marker in smoke inhalation injury
    Hayun, Yehiel
    Shoham, Yaron
    Krieger, Yuval
    Silberstein, Eldad
    Douvdevani, Amos
    Ad-El, Dean
    [J]. MEDICINE, 2019, 98 (12)
  • [5] Circulating Cell-Free DNA as Inflammatory Marker in Egyptian Psoriasis Patients
    Anani, Haneya A. A.
    Tawfeik, Amany M.
    Maklad, Soheir S.
    Kamel, Abeer M.
    El-Said, Enas E.
    Farag, Asmaa S.
    [J]. PSORIASIS-TARGETS AND THERAPY, 2020, 10 : 13 - 21
  • [6] Cell-free, Circulating Dna As A Novel Marker For Player Load In Soccer
    Haller, Nils
    Helmig, Susanne
    Taenny, Pascal
    Petry, Julian
    Schmidt, Sebastian
    Simon, Perikles
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (05): : 3 - 3
  • [7] Circulating cell-free DNA as a diagnostic and prognostic marker for cervical cancer
    Parida, Preetiparna
    Baburaj, Gayathri
    Rao, Mahadev
    Lewis, Shirley
    Damerla, Rama Rao
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (02) : 307 - 316
  • [8] Circulating cell-free DNA as a biomarker for molecular diagnosis of Neurocysticercosis
    Mehta, Yashvi
    Kaur, Upninder
    Shree, Ritu
    Modi, Manish
    Lal, Vivek
    Sehgal, Rakesh
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 461
  • [9] The potential of circulating cell-free tumor DNA as a diagnostic marker of ovarian cancer
    Yamamoto, Misa
    Sawada, Kenjiro
    Shimizu, Aasa
    Matsumoto, Yuri
    Kodama, Michiko
    Hashimoto, Kae
    Kimura, Tadashi
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (11) : 42 - 42
  • [10] Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer
    Iqbal, Sobuhi
    Vishnubhatla, Sreenivas
    Raina, Vinod
    Sharma, Surabhi
    Gogia, Ajay
    Deo, Suryanarayana S. V.
    Mathur, Sandeep
    Shukla, Nutan Kumar
    [J]. SPRINGERPLUS, 2015, 4